Abstract: The present invention relates to a composition comprising a naphthoquinone-based compound as an active ingredient, for preventing or ameliorating fatigue, cachexia, pain, cognitive decline, and hematopoietic stem cell reduction which are side effects related to anticancer drug treatment.
Type:
Application
Filed:
April 28, 2017
Publication date:
March 21, 2019
Applicant:
NADIAN BIO LTD.
Inventors:
Hong Seob So, Hyung-Jin Kim, Gi-Su Oh, Seunghoon Lee, Dipendra Khadka